These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 4597792

  • 1. Boric acid treatment of vulvovaginal candidiasis.
    Swate TE, Weed JC.
    Obstet Gynecol; 1974 Jun; 43(6):893-5. PubMed ID: 4597792
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis.
    Jovanovic R, Congema E, Nguyen HT.
    J Reprod Med; 1991 Aug; 36(8):593-7. PubMed ID: 1941801
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N.
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [Abstract] [Full Text] [Related]

  • 6. [Vulvovaginal candidiasis: a therapeutic approach].
    Battaglia F, Mariani L, Anglana F, Milite V, Quattrini M, Plotti F, Tomao F, Plotti G.
    Minerva Ginecol; 2005 Apr; 57(2):131-9. PubMed ID: 15940073
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of vulvovaginal candidiasis with boric acid powder.
    Van Slyke KK, Michel VP, Rein MF.
    Am J Obstet Gynecol; 1981 Sep 15; 141(2):145-8. PubMed ID: 7282789
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of recurrent vulvovaginal candidiasis.
    Ringdahl EN.
    Am Fam Physician; 2000 Jun 01; 61(11):3306-12, 3317. PubMed ID: 10865926
    [Abstract] [Full Text] [Related]

  • 13. Teratogenic effects of vaginal boric acid treatment during pregnancy.
    Acs N, Bánhidy F, Puhó E, Czeizel AE.
    Int J Gynaecol Obstet; 2006 Apr 01; 93(1):55-6. PubMed ID: 16530197
    [No Abstract] [Full Text] [Related]

  • 14. Vulvovaginal candidiasis.
    Cooke CW.
    Obstet Gynecol; 1976 Nov 01; 48(5):631-2. PubMed ID: 980292
    [No Abstract] [Full Text] [Related]

  • 15. [Study on Candida no-albicans species and its relation to recurrent vulvovaginal candidiasis].
    Buitrón García R, Romero Cabello R, Cruz Talonia F, Bonifaz A, Zarama Marquez F.
    Ginecol Obstet Mex; 2002 Sep 01; 70():431-6. PubMed ID: 12448051
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Constraint on boric acid resistance and tolerance evolvability in Candida albicans.
    Syvolos Y, Salama OE, Gerstein AC.
    Can J Microbiol; 2024 Sep 01; 70(9):384-393. PubMed ID: 38754137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.